Metalyse - supply shortage

Resolved
tenecteplase
Shortage Human

Shortage information

The shortage affecting Metalyse has been resolved and the information and recommendations which were issued during the shortage no longer apply.

Key facts

Medicines affected
Metalyse
Supply shortage status
Resolved
International non-proprietary name (INN) or common name
tenecteplase
Therapeutic area (MESH)
Myocardial Infarction
Pharmaceutical forms affected
Powder and solvent for solution for injection
Strengths affected
  • 8,000 units (40 mg)
  • 10,000 units (50 mg)
Availability of alternatives
Yes

Key dates

First published
Last updated

Share this page